Glycosaminoglycan characterization methodologies: probing biomolecular interactions.

Interactions between glycans and proteins are central to many of the regulatory processes within biology. The development of analytical methodologies that enable structural characterization of glycosaminoglycan oligosaccharides has fostered improved understanding of the specificity of these biomolecular interactions. This facilitates an appreciation in understanding how changes in GAG structure can regulate physiology as well as pathology. While there are various techniques for studying the interaction of GAGs with proteins, in this chapter we focus on two approaches. First, an integrated analytical methodology, surface non-covalent affinity mass spectrometry (SNA-MS), is described to isolate, enrich, and sequence tissue-derived GAGs that bind to specific proteins. The broad applicability of this powerful platform offers an insight into how changes in cell-surface and extracellular GAG composition and sequence influences the ability of cells and tissues to dynamically alter responses to signaling molecules. Thus, this approach provides a window into understanding how changes at a molecular level manifest with respect to cellular phenotype. Second, surface plasmon resonance, or SPR, represents an additional platform for the study of protein-polysaccharide interaction, specifically for measuring the binding between GAG chains and proteins.

[1]  Priyabrata Pattnaik,et al.  Surface plasmon resonance , 2005, Applied biochemistry and biotechnology.

[2]  Robert J Linhardt,et al.  A highly stable covalent conjugated heparin biochip for heparin-protein interaction studies. , 2002, Analytical biochemistry.

[3]  Heather Desaire,et al.  Detection and quantification of the sulfated disaccharides in chondroitin sulfate by electrospray tandem mass spectrometry , 2000, Journal of the American Society for Mass Spectrometry.

[4]  M. Götte,et al.  Functions of cell surface heparan sulfate proteoglycans. , 1999, Annual review of biochemistry.

[5]  L. Sturiale,et al.  MALDI mass spectrometry as a tool for characterizing glycosaminoglycan oligosaccharides and their interaction with proteins. , 2001, Seminars in thrombosis and hemostasis.

[6]  K. Biemann,et al.  Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Rudland,et al.  Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts. , 2002, The Biochemical journal.

[8]  D. Ron,et al.  Dermatan Sulfate Binds and Potentiates Activity of Keratinocyte Growth Factor (FGF-7)* , 2002, The Journal of Biological Chemistry.

[9]  P. Maurel,et al.  Localization of aggrecan and versican in the developing rat central nervous system , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.

[10]  Z. Shriver,et al.  Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Mourão,et al.  Dermatan sulfate is the predominant antithrombotic glycosaminoglycan in vessel walls: implications for a possible physiological function of heparin cofactor II. , 2005, Biochimica et biophysica acta.

[12]  D G Myszka,et al.  Advances in surface plasmon resonance biosensor analysis. , 2000, Current opinion in biotechnology.

[13]  L. Suva,et al.  Heparan sulfate proteoglycans and heparanase--partners in osteolytic tumor growth and metastasis. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[14]  J. Zaia,et al.  Tandem mass spectrometric determination of the 4S/6S sulfation sequence in chondroitin sulfate oligosaccharides. , 2001, Analytical chemistry.

[15]  J. Trowbridge,et al.  Dermatan sulfate: new functions from an old glycosaminoglycan. , 2002, Glycobiology.

[16]  Balagurunathan Kuberan,et al.  Analysis of heparan sulfate oligosaccharides with ion pair-reverse phase capillary high performance liquid chromatography-microelectrospray ionization time-of-flight mass spectrometry. , 2002, Journal of the American Chemical Society.

[17]  K. Biemann,et al.  Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Serge Pérez,et al.  Prospects for glycoinformatics. , 2005, Current opinion in structural biology.

[19]  J. Zaia,et al.  Compositional analysis of glycosaminoglycans by electrospray mass spectrometry. , 2001, Analytical chemistry.

[20]  Z. Shriver,et al.  Direct isolation and sequencing of specific protein-binding glycosaminoglycans , 2001, Nature Medicine.

[21]  H. Kitagawa,et al.  Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. , 2003, Current opinion in structural biology.

[22]  H. M. Geller,et al.  Proteoglycans Provide Neurite Guidance at an Astrocyte Boundary , 1997, Molecular and Cellular Neuroscience.

[23]  W. Kett,et al.  Protein-heparin interactions measured by BIAcore 2000 are affected by the method of heparin immobilization. , 2002, Analytical biochemistry.

[24]  R. Eisenberg,et al.  Characterization of a Heparan Sulfate Octasaccharide That Binds to Herpes Simplex Virus Type 1 Glycoprotein D* , 2002, The Journal of Biological Chemistry.